Companies Profiled in Point of Care Molecular Diagnostics Market are Abaxis, Inc., Bayer, Bayer Crop Science, Sysmex Corporation

Global Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth. Quick and precise detection of causative agents is of utmost importance in infectious disease emergency cases as the inaccuracy in disease detection leads to incorrect treatment which escalates disease spreading risk. Point of care molecular diagnostic assays permit the timely detection of the causative agent enabling effective disease control.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2210

Isothermal amplification technology should exhibit lucrative growth as they are used as an alternative to polymerase chain reaction. Thermocycling machines are not required in the use of this technology and it can mostly be performed with reduced time, greater accuracy and high throughput. The increased reliability of isothermal amplification will drive segment growth. The added benefit of constant temperature of amplification provides a high potential for simple integration of this technique in PoC devices.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Abaxis, Inc.
• Kalila Medical (Abbott Laboratories)
• Bayer
• Bayer Crop Science
• Sysmex Corporation
• bioMérieux
• Bio-Rad Laboratories
• Danaher Corporation
• ORASURE TECHNOLOGIES, INC.
• Roche Diagnostics Middle East

Flu molecular diagnostics market held significant share in 2016. The segment is poised to grow at a rapid pace owing to the increase global burden of seasonal influenza. Flu prevalence is growing among the ageing population, new born children and individuals afflicted with certain chronic conditions who have a higher susceptibility to the disease. Increasing availability of screening tests for A and B virus infectious should further stimulate Flu PoC test demand.

Hepatitis B infection is also amongst the most important global health problems affecting large population pool. Laboratory detection of HBV is based on immune detection of HBsAg. However, the problem of HBsAg non-detection owing to diagnostic escape mutations in the isotopes or low antigen levels have greatly emphasized importance of molecular biology tools for virus detection stimulating the demand.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2210

U.S. point of care molecular diagnostics market held significant revenue share in 2016. Growing infectious disease incidence leading to huge healthcare costs and increasing focus on preventive care to reduce the economic burden are propelling the PoC molecular diagnostics market size. Increasing demand for fast and portable tests along with rising diagnostics adoption rate for use in and outside hospital settings serves as a highly influential factor driving industry growth.

Point of Care (PoC) Molecular Diagnostics Market by Technology
• Polymerase Chain Reaction (PCR)
• Real Time PCR
• DNA / RNA Purification
• In Situ Hybridization
• Chips and Microarrays
• Mass Spectrometry
• Sequencing
• Isothermal Amplification

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.